Martingale Asset Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-252
| Closed | -$87K | – | 1039 |
|
|
2019
Q3 | $87K | Hold |
252
| – | – | ﹤0.01% | 984 |
|
|
2019
Q2 | $232K | Hold |
252
| – | – | ﹤0.01% | 978 |
|
|
2019
Q1 | $402K | Hold |
252
| – | – | ﹤0.01% | 912 |
|
|
2018
Q4 | $471K | Hold |
252
| – | – | 0.01% | 865 |
|
|
2018
Q3 | $594K | Sell |
252
-16
| -6% | -$37.7K | 0.01% | 820 |
|
|
2018
Q2 | $923K | Sell |
268
-43
| -14% | -$148K | 0.01% | 761 |
|
|
2018
Q1 | $883K | Hold |
311
| – | – | 0.01% | 749 |
|
|
2017
Q4 | $801K | Buy |
311
+2
| +0.6% | +$5.15K | 0.01% | 741 |
|
|
2017
Q3 | $878K | Buy |
309
+86
| +39% | +$244K | 0.01% | 763 |
|
|
2017
Q2 | $527K | Buy |
223
+139
| +165% | +$328K | 0.01% | 818 |
|
|
2017
Q1 | $213K | Hold |
84
| – | – | ﹤0.01% | 911 |
|
|
2016
Q4 | $191K | Sell |
84
-7
| -8% | -$15.9K | ﹤0.01% | 943 |
|
|
2016
Q3 | $228K | Sell |
91
-1
| -1% | -$2.51K | ﹤0.01% | 912 |
|
|
2016
Q2 | $283K | Buy |
+92
| New | +$283K | ﹤0.01% | 756 |
|
|
2016
Q1 | – | Sell |
-64
| Closed | -$330K | – | 874 |
|
|
2015
Q4 | $330K | Buy |
+64
| New | +$330K | 0.01% | 736 |
|